Autoantibodies: Powerful Biomarkers in Cancer Precision Medicine

In the U.S. there are only 4 regular screening protocols for cancer, which detect only 29% of all cancers. Serum contains a myriad of autoantibodies with unique information defining an individual’s immuno-signature, which can include a window into early tumor presence.

Download the white paper to learn about:

  • How autoantibodies are elicited by cancer
  • Overcoming barriers to cancer diagnosis & prognosis with autoantibody discovery
  • Autoantibodies & predicting irAEs
  • Advantages of autoantibody discovery to pathway analysis & drug development

Request Free!